Use of topical therapies during pregnancy and the postpartum period
[ N/A ]
Tarih
2022
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Springer International Publishing
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Treatment selection choices during pregnancy should be based on the US Food and Drug Administration (FDA) risk categories. The FDA categorized drugs as A, B, C, D, and X based on animal and human studies. Category D and category X drugs should be avoided during pregnancy, whereas category A and category B drugs are safe to use. Category C drugs should be considered case by case as there are no adequate studies on humans, but animal studies have shown the adverse effects on fetus. © The Author(s), under exclusive license to Springer Nature Switzerland AG 2022.
Açıklama
Anahtar Kelimeler
Drug therapy, Otolaryngology, Postpartum period, Pregnancy, Topical administration
Kaynak
ENT Diseases: Diagnosis and Treatment during Pregnancy and Lactation
WoS Q Değeri
Scopus Q Değeri
N/A
